Dear Editor,
We thank Yasri and Wiwanitkit for their comments on our work [1] . In their response, they showed other factors that might alter the serum leptin level and this might be a limitation in using serum leptin as a clinical parameter in metabolic syndrome such in liver disease [1] . Many factors may affect serum leptin levels such as physical activity, statin used and pharmacological intervention toward against renin-angiotensin system [2] . In our study did not show significantly different of leptin levels between those treated or not with statins, fibrates, or antidiabetic drugs on peripheral arterial stiffness in patients with type 2 diabetes mellitus [3] . Leptin is known to contribute to fibrogenesis in chronic liver diseases [4] . However, studies on leptin levels and liver disease are controversial [4] . Further studies are needed to confirm the liver disease on serum leptin levels in the future.
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